@KalaGhazi #CARVANA CO looks like its going for a heavy ride!
@KalaGhazi #ObsEva SA has been volatile last week I do see an upside Good luck
Hi everyone, this is KalaGhazi and today I will be talking about Reata that just rocketed 200% yesterday. Reata Pharmaceuticals RETA stock skyrocketed almost 200% on Wednesday, a day after the FDA approved its drug Skyclarys, or omaveloxolone, across a broad patient population of an ultra-rare disease called Friedreich’s ataxia. Shares of Reata have surged 200.3%...
OMG this garbage has been run up too fast by the pump n dump crowd! Look at KTRA, this is what happens to these up then back down to reality. Money losing FDA blah blah overvalued
Banks has a lot of Long Hedges Open on these tickers, they have been overall short the last 1,5 years. Now in March they began to close their first Long Hedge position. Question right now is, did they build up big position yet for the longside, or they just sold their long Hedge and want price to go down further. If we hold the lows of 0,59 here - no weekly close...
I decided to start this new format to take advantage of short opportunities that arise when a week stock has gone parabolic. I have some criteria to sift through opportunities and choose the best: 1) The company is relatively unknown (normally belongs to the OTC market) and financially weak (medical companies normally satisfy these criteria) 2) The company has...
Short squeeze stocks have become a favorite recently. KALA has started getting wrapped into the conversation. Looking at details from sites like FinViz, short float is around 20% meanwhile the float itself shows to be around 42 million shares. Plotting some levels, you'll notice that KALA is still in the lower channel on the fib retracement slowly heading toward...
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye. The company's two marketed products are EYSUVIS and INVELTYS. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to...
Kala Pharmaceuticals Announces FDA Acceptance of New Drug Application for EYSUVIS™ for Dry Eye Disease -- FDA Sets PDUFA Goal Date of October 30, 202 The idea is to go long hoping to get the good news from the FDA.
NASDAQ:KALA KALA PHARMACEUTICALS INC $KALA is forming a CUP & Handle formation with a leading BO on the OBV index. The stock had also a lot of insider buying power and positive news with their EYSUVIS (a dry eye disease)